title: Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists.
authors.affiliation: Department of Medicinal Chemistry, Glaxo Research and Development Ltd., Ware, Hertfordshire, England.
authors.forename: J W
authors.initials: JW
authors.lastname: Clitherow
authors.forename: D I
authors.initials: DI
authors.lastname: Scopes
authors.forename: M
authors.initials: M
authors.lastname: Skingle
authors.forename: C C
authors.initials: CC
authors.lastname: Jordan
authors.forename: W
authors.initials: W
authors.lastname: Feniuk
authors.forename: I B
authors.initials: IB
authors.lastname: Campbell
authors.forename: M C
authors.initials: MC
authors.lastname: Carter
authors.forename: E W
authors.initials: EW
authors.lastname: Collington
authors.forename: H E
authors.initials: HE
authors.lastname: Connor
authors.forename: G A
authors.initials: GA
authors.lastname: Higgins
mesh_terms: D000813:Anilides / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D002490:Central Nervous System / Q000378:metabolism; D004285:Dogs; D006168:Guinea Pigs; D012702:Serotonin Antagonists
chemical_list: D000813:Anilides; D012702:Serotonin Antagonists; C034595:benzanilide